SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biogen
BIIB 186.00-0.5%3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Michael H. Dragon who wrote (19)9/9/1996 3:22:00 PM
From: Harold Engstrom   of 1686
 
Thanks for your suggestion. I have been contemplating Genzyme since last year when they had another offering at roughly $60/share. At the time I thought that was overpriced, but now it is selling at a 25% discount and as you point out, they have increasingly stronger fundementals and future. I think I may buy some. Genetics Institute continues to fall in price as well and its fundemental story remains very strong (as far as I know).

Thanks again,

H
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News